{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:08:42Z","timestamp":1785769722315,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/coc.0b013e3182467b9a","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T15:44:49Z","timestamp":1332431089000},"page":"258-260","source":"Crossref","is-referenced-by-count":22,"title":["Outcome of Patients With Renal Cell Carcinoma Metastatic to the Brain Treated With Sunitinib Without Local Therapy"],"prefix":"10.1097","volume":"36","author":[{"given":"Zita Dubauskas","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar M.","family":"Tannir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.2008.20.1293","article-title":"Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.","volume":"27","author":"Motzer","year":"2009","journal-title":"J Clin Oncol"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01059958","article-title":"High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma.","volume":"23","author":"Seaman","year":"1995","journal-title":"J Neurooncol"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/annonc\/mdm275","article-title":"Complete cerebral response with sunitinib for metastatic renal cell carcinoma.","volume":"18","author":"Medioni","year":"2007","journal-title":"Ann Oncol"},{"key":"R5-8-20210128","first-page":"4255","article-title":"Brain metastasis in renal cell cancer responding to sunitinib.","volume":"27","author":"Koutros","year":"2007","journal-title":"Anticancer Res"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-008-0917-1","article-title":"Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species.","volume":"64","author":"Haznedar","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/cncr.25452","article-title":"Sunitinib in metastatic renal cell carcinoma patients with brain metastases.","volume":"117","author":"Gore","year":"2011","journal-title":"Cancer"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.2007.13.5814","article-title":"Brain metastases in patients with renal cell carcinoma receiving new targeted therapy.","volume":"26","author":"Helgason","year":"2008","journal-title":"J Clin Oncol"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/JTO.0b013e3181b62572","article-title":"Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.","volume":"11","author":"Katayama","year":"2009","journal-title":"J Thorac Oncol"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-008-9623-4","article-title":"Erlotinib therapy in a patient with non-small cell lung cancer and brain metastases.","volume":"90","author":"Altavilla","year":"2008","journal-title":"J Neurooncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-201306000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:17:50Z","timestamp":1785766670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201306000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3182467b9a","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}